Applications published 16 May 2007

Improved topical skin care compsns
Avon Products 1781158*

Controlled release formulations of enzymes, micro-organisms and antibodies with mucoadhesive polymers
Amano Enzyme 1784160*

Controlled-release formulation comprising tamsulosin hydrochloride
Instytut Farmaceutyczny 1784161*

System and method for modifying a fluid for oral administration
Remote Clinical Solutions 1784162*

Nano-emulsion, the use thereof and preparation method thereof
Kim, Young Dae; Park, Jung Soo; Kim, Ji Soo; Kim, Ji Soo 1784163*

Methods for transmembrane treatment and prevention of otitis media
Piedmont Pharmaceutica 1784164*

Stable particle formulations of erythropoietin receptor agonists
Alza 1784165*

Compsns comprising 5-amino-2-hydroxybenzoic acid and a reducing sugar
Procter & Gamble 1784166*

Multi-layer tablets and bioadhesive dosage forms
Spherics 1784167*

Method of use of herbal compsns
Medigreen Biotechnology 1784168*

Polymeric adhesive matrix with salified carboxylic groups for transdermal use
Bouty 1748169*

Atrium patch
Labtec Gesellschaft fuer Technologische Forschung und Entwicklung 1784170*

Topical otic compsns and methods of topical treatment or prevention of otic infections
Insite Vision 1784171*

Cancer chemotherapy
Hutchison Medipharma Enterprises 1784172*

Pharmaceutical compsn for preventing and treating metabolic diseases containing alpha-arylmethoxyacrylate derivatives
Korea Research Institute of Chemical Technology; Oscotec 1784173*

A pharmaceutical compsn comprising gabapentin
Zambon 1784174*

Inhibitors of AKT activity
Merck 1784175*

Compsn comprising lactic acid and lactoferrin
Nastor Medical 1784176*

Novel formulation for L-tryptophane comprising cabidopa/benserazide
Dr Kamprad 1784177*

Aryl (or heteroaryl) azolylcarbinols
Laboratoires del Dr Esteve 1784178*

Combination therapy for treating cyclooxygenase-2 mediated diseases or conditions in patients at risk of thrombotic cardiovascular events
Merck 1784179*

2-amino 1H imidazo ring systems and methods
3M Innovative Properties 1784180*

VEGF inhibition
Newsouth Innovations Pty Ltd 1784181*

2-sulphanyl-benzimidazol-1-yl-acetic acid derivatives as CRTH2 antagonists
Actelion Pharmaceuticals 1784182*

Processes for the preparation of isothiazole derivatives
Pfizer Products 1784183*

The use of N-aryl diazaspiracyclic compounds in the treatment of addiction
Targacept 1784184*

Chemical compounds
SmithKline Beecham 1784185*

Methods for treating or preventing erectile dysfunction or urinary incontinence
Inotek Pharmaceuticals 1784186*

Androgen receptor modulators
Merck 1784187*

Fused triazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
Merck 1784188*

Modulators of HCV replication
Istituto di Ricerche di Biologia Molecolate P Angeletti 1784189*

Substituted purinyl derivatives with immunomodulator and chemoprotective activity and use alone or with medium-chain length fatty acids or glycerides
Prometic Biosciences 1784190*

Treatment of psychological and cognitive disorders using a cholesterol-lowering agent in combination with an antidepressant
The McLean Hospital Corp 1784191*

Vaginal cream compsns, kits thereof and methods of using thereof
Duramed Pharmaceuticals; Ahmed, Salah; Ben-Maimon, Carole; Hait, Howard 1784192*

Compsn and method for treatment and prevention of atherosclerosis
Howard J Smith 1784193*

Histone deacetylase inhibitors
Merck; Aton Pharma 1784194*

Pharmaceutical compsn comprising galactose, selenium, vitamin E and/or phosphatidyl choline, and pharmaceutical uses of galactose
Mosetter, Kurt 1784195*

Ceramide derivatives as modulators of immunity and autoimmunity
Albert Einstein College of Medicine of Yeshiva University 1784196*

Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulphate for treatment of asthma, chronic obstructive pulmonary disease or allergic rhinitis
EpiGenesis Pharmaceuticals 1784197*

Topical antiviral therapeutic and prophylactic treatment of adenoviruses and their associated diseases
Redox Pharmaceutical Corp Audubon Biomedica 1784198*

Compounds for the treatment of marijuana dependence, withdrawal, and usage
McLean Hospital Corp 1784199*

Method and compsn for modulation of systemic inflammatory responses syndrome (SIRS)
Medical Research Fund at the Tel Aviv Sourasky Medical Center 1784200*

Physiologically active compsn
Cargill 1784201*

Method of treating, preventing, inhibiting or reducing damage to cardiac tissue
The University of Texas Southwestern Medical Centre at Dallas; Regenerx Biopharmaceuticals 1784204*

Stretch mark treatment with botulinum toxin
Allergan 1784205*

Antimicrobial peptides derived from CAP18
OctoPlus Sciences; Academische Ziekenhuis Leiden 1784206*

ICA512 couples insulin secretin and gene expression in beta cells
Technische Universitaet Dresden Medizinische Fakultaet Carl Gustav Carus 1784207*

Use of a DNA molecule as vaccine adjuvant
Forinnova 1784208*

Contraceptives based on SP22 and SP22 antibodies
US Environmental Protection Agency 1784209*

Carrier conjugates of GNRH-peptides
Cytos Biotechnology 1784210*

Immunogenic compsns for gram positive bacteria such as streptococcus agalactiae
Novartis Vaccines and Diagnostics 1784211*

Polypeptides for inducing a protective immune response against Staphylococcus aureus
Merck 1784212*

Improvements relating to meningococcal outer membrane vesicles
Novartis Vaccines and Diagnostics 1784213*

Multivalent meningococcal derivatised polysaccharide-protein conjugates and vaccine
Sanofi Pasteur 1784214*

1,4 O-linked saccharose derivatives for stabilising antibodies or antibody derivatives
Boehringer Ingelheim Pharma 1784215*

S100 protein inhibitors for treating leukemia
Universite Laval 1784216*

Treatment of HIV infection by T-cell modulation
Bayer Schering Pharma Aktiengesellschaft 1784217*

Nutritional compsn comprising immunoglobulins and oligosaccharides
Nutricia 1784218*

Stabilising formulations
Wyeth 1784219*

Bacterial iron acquisition targets
The University of Western Ontario 1784220*

Method for the treatment and prevention of infection using anti-selectin agents
Ligocyte Pharmaceuticals; Montana State University; Montana Hall 1784221*

Nutritional compsn comprising indigestible oligosaccharides
NV Nutricia 1784222*

Compsn comprising plant and/or fish oils and non-oxidisable fatty acid entities
Thia Medica 1784223*

EGFR kinase inhibitor combinations for treating respiratory and gastrointestinal disorders
Boehringer Ingelheim International 1784224*

Biomimetic of Evodia rutaecarpa fruit extract for amelioration of inflammation
Applied Genetics Incorporated Dermatics 1784225*

Cyanine dyes conjugated with antibodies for the diagnosis of micrometastasis
Bayer Schering Pharma Aktiengesellschaft 1784226*